Ethnicity delineates different genetic pathways in malignant glioma.

作者: John K. Wiencke , Kenneth D Aldape , Rei Miike , Karl T. Kelsey , Richard L. Davis

DOI:

关键词: PopulationRisk factorBrain tumorPolymorphism (computer science)Odds ratioImmunohistochemistryGliomaBiologyPathologyCarcinogenesis

摘要: In the United States and San Francisco Bay Area, whites are nearly twice as likely non-whites to develop brain cancer. To test whether prevalence types of alterations in p53 pathway tumor development may explain some this difference risk, we have analyzed status astrocytic gliomas from a population-based sample cases within our Area Adult Glioma Study. We identified mutations exons 5-8 using DNA extracted formalin-fixed paraffin-embedded tissue blocks 146 26 with glioma by PCR-single-strand conformation polymorphism direct sequencing. Tumor P53 protein (TP53) immunohistochemistry (IHC) available for 164 these showed that tumors 50% (13 26) 32% (44 138) contained intense IHC staining TP53, indicating persistence TP53 protein. Irrespective status, 42% (11 versus 13% (19 146) (age/gender-adjusted odds ratio, 5.7; 95% confidence interval, 2.2-15.1; P = 0.0004). Patients mutation-positive were also significantly younger than patients mutation-negative somewhat more be female. A higher proportion had transition mutations, but there similar proportions transversion non-whites. Whites stained intensely (78 82%, respectively). Because risk population, less those mutation suggests at common type gliomas, which do not contain mutations.

参考文章(26)
K Ichimura, Maria Bondesson Bolin, Helena M Goike, Esther E Schmidt, Ahmad Moshref, V Peter Collins, Deregulation of the p14ARF/MDM2/p53 Pathway Is a Prerequisite for Human Astrocytic Gliomas with G1-S Transition Control Gene Abnormalities Cancer Research. ,vol. 60, pp. 417- 424 ,(2000)
James F. Gusella, Andreas von Deimling, Otmar D. Wiestler, David N. Louis, David W. Yandell, Mari Paz Rubio, Accumulation of Wild Type p53 Protein in Human Astrocytomas Cancer Research. ,vol. 53, pp. 3465- 3467 ,(1993)
Inskip D. Peter, Martha S. Linet, Ellen F. Heineman, Etiology of Brain Tumors in Adults Epidemiologic Reviews. ,vol. 17, pp. 382- 414 ,(1995) , 10.1093/OXFORDJOURNALS.EPIREV.A036200
David N. Louis, The p53 gene and protein in human brain tumors. Journal of Neuropathology and Experimental Neurology. ,vol. 53, pp. 11- 21 ,(1994) , 10.1097/00005072-199401000-00002
Sandra A. Rempel, Molecular biology of central nervous system tumors. Current Opinion in Oncology. ,vol. 10, pp. 179- 185 ,(1998) , 10.1097/00001622-199805000-00002
Margaret Wrensch, Melissa L. Bondy, John Wiencke, Michael Yost, Environmental risk factors for primary malignant brain tumors: A review Journal of Neuro-Oncology. ,vol. 17, pp. 47- 64 ,(1993) , 10.1007/BF01054274
Frank B. Furnari, Su Huang, Webster K. Cavenee, Molecular biology of malignant degeneration of astrocytoma. Pediatric Neurosurgery. ,vol. 24, pp. 41- 49 ,(1996) , 10.1159/000121013
Iakovos Sigalas, A. Hilary Calvert, John J. Anderson, David E. Neal, John Lunec, Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nature Medicine. ,vol. 2, pp. 912- 917 ,(1996) , 10.1038/NM0896-912
Elizabeth W. Newcomb, William J. Madonia, Sobha Pisharody, Frederick F. Lang, Maxim Koslow, Douglas C. Miller, A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme Brain Pathology. ,vol. 3, pp. 229- 235 ,(1993) , 10.1111/J.1750-3639.1993.TB00749.X
David N. Louis, Andreas Von Deimling, Richard Y. Chung, Mari-Paz Rubio, Jean M. Whaley, Robert H. Eibl, Hiroko Ohgaki, Otmar D. Wiestler, Ann D. Thor, Bernd R. Seizinger, Comparative study of p53 gene and protein alterations in human astrocytic tumors. Journal of Neuropathology and Experimental Neurology. ,vol. 52, pp. 31- 38 ,(1993) , 10.1097/00005072-199301000-00005